Blumhouse, Atomic Monster Unite as Blumhouse Atomic
Horror studios Blumhouse and Atomic Monster have adopted the shared umbrella name Blumhouse Atomic, with both labels continuing as distinct production banners.
Updated on Nov. 3, 2026 in Horror
James Wan and Jason Blum announced the umbrella name Blumhouse Atomic for their merged horror production companies. Blumhouse and Atomic Monster will continue as distinct production labels under the new umbrella.
Why it matters
The merged banners have generated more than $2.5 billion in worldwide box office from combined production budgets of less than $330 million. The umbrella structure signals a broader push into television, games, and live experiences.
The merged banners have generated more than $2.5 billion in worldwide box office on combined production budgets of less than $330 million, with $1.3 billion of that total coming in 2026. The split of 2026 earnings between the two labels has not been disclosed.
The players
James Wan
James Wan is a filmmaker and producer known for founding Atomic Monster and creating the Saw and Insidious horror franchises.
Jason Blum
Jason Blum is a producer who founded Blumhouse Productions, known for backing low-budget horror films such as Paranormal Activity and Get Out.
The details
Blumhouse and Atomic Monster merged in 2024 and will keep operating as separate production labels. Creative teams under each banner will develop and produce film and television projects, while the Blumhouse Atomic name unites them. Curry Barker's Obsession and Kane Parsons' Backrooms are among the year's biggest hits, and Saw is being brought back to James Wan with a new chapter in development.
Timeline
2024: Blumhouse and Atomic Monster merged.
2026: Blumhouse Atomic generated $1.3 billion in box office.
November 3, 2026: The Blumhouse Atomic umbrella name was announced.
Industry Dynamics
The consolidation follows the broader horror-genre strategy of low-budget production paired with high returns that Blumhouse Productions built over the past decade. Combining the two labels under one umbrella positions them to expand into adjacent media rather than compete with one another in the same production pipeline.
Viewers will find the labels' projects through their existing release channels as each banner develops film and television work. The source does not specify new platform exclusivity, pricing, or release dates for titles under the Blumhouse Atomic umbrella.
The takeaway
Studio consolidation in horror can pair shared branding with separate creative identities, letting each label keep its own voice while the umbrella opens new revenue streams. Readers following the genre should watch how the combined banners expand beyond film.
Further reading
Explore more Horror coverage for context on the genre's studio landscape.
